Report Thumbnail
Product Code MR09140194690Q
Published Date 2023/9/20
English130 PagesGlobal

Robotic Arms Market Research Report Forecast to 2030MedicalDevice_MedTech Market


Report Thumbnail
Product Code MR09140194690Q◆The Sep 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/9/20
English 130 PagesGlobal

Robotic Arms Market Research Report Forecast to 2030MedicalDevice_MedTech Market



Abstract


Summary

Robotic Arms Market Research Report Forecast to 2030 Market Overview The worldwide Robotic Prosthetics Market is anticipated to register a healthy CAGR of 9.30% during the review period. The Global Osteoporosis Foundation's Mechanical Prosthetics Market research states that in 2017, one in three women and one in five men over the age of fifty will certainly suffer the negative effects of a delicate break at some point in their abundant existence. Additionally, 79,000 hip breaks and 536,000 delicacy breaks are experienced by people in the United Kingdom on a regular basis. The market development has been accelerated by the increase in breaks, growing awareness among people regarding the utilization of innovative advancements and increasing medical consideration expenditure. In any case, openness of exorbitant treatment and vulnerable reimbursement game plans in the making districts of the world are a part of the factors, that could control the Market development during the forecast period. A portion of the additional elements validating the Market development integrates the reliably expanding people and urbanization. Additionally, the Market players put fundamental endeavors and considerable aggregates into working on these prosthetics. Advancements are dealt with well, driving the development of the Market Viewpoint. Nonetheless, factors, for example, lacking reimbursement approaches for gaining advanced mechanics prosthetics, are assessed to hinder the market development, especially in the created economies. Integrating general advances like Man-made consciousness alongside three-dimensional imaging will uphold the Market development, vehemently influencing market development. Segment Overview Based on the technology utilized, the Robotic Prosthetics Market is sectioned into MPC Prosthetics and Myoelectrical Prosthetics. Based on an extremity, the Robotic Prosthetics Market is sectioned into the furthest point and lower limit. Regional Analysis The Americas, which contain North America and South America, are partitioned into different nation-level business sectors. Among these, the U.S. drives the development of the American local Robotic Prosthetics Market. The locale's high pervasiveness of muscular illnesses has brought about the popularity of robotic prosthetics. High medical care speculations and the presence of a created medical care area with partiality toward the reception of trendsetting innovation are some different variables driving business sector development. Remarkably, Mexican Americans are a great danger for osteoporosis and, as such, are defenceless against bone issues that might bring about a requirement for Robotics Prosthetics. Major Players The major market key players of Robotic Prosthetics are mentioned below HDT Global Inc (U.S.), Smith & Nephew (U.K), Intuitive Surgical, Inc. (U.S.), ZOLL Medical Corporation (U.S.), Hansen Medical, Inc. (U.S.), Touch Bionics Inc. (U.S.), Transenterix, Inc. (U.S.), Aethon (U.S.), Syn Touch, LLC (U.S.), Re Walk Robotics (Israel), Shadow Robot Company (U.K), Medrobotics Corporation (U.S.), Stryker Corporation (U.S.), KUKA Roboter GmbH (Germany), and Mazor Robotics Ltd. (Israel).

Table of Contents

  • 1 REPORT PROLOGUE

  • 2 MARKET INTRODUCTION

    • 2.1 DEFINITION
    • 2.2 SCOPE OF THE STUDY
      • 2.2.1 RESEARCH OBJECTIVE
      • 2.2.2 ASSUMPTIONS
      • 2.2.3 LIMITATIONS
  • 3 RESEARCH METHODOLOGY

    • 3.1 INTRODUCTION
    • 3.2 PRIMARY RESEARCH
    • 3.3 SECONDARY RESEARCH
    • 3.4 MARKET SIZE ESTIMATION
  • 4 MARKET DYNAMICS

    • 4.1 DRIVERS
    • 4.2 RESTRAINS
    • 4.3 OPPORTUNITIES
    • 4.4 CHALLENGES
    • 4.5 MACROECONOMIC INDICATORS
    • 4.6 TECHNOLOGY TRENDS & ASSESSMENT
  • 5 MARKET FACTOR ANALYSIS

    • 5.1 PORTERS FIVE FORCES ANALYSIS
      • 5.1.1 BARGAINING POWER OF SUPPLIERS
      • 5.1.2 BARGAINING POWER OF BUYERS
      • 5.1.3 THREAT OF NEW ENTRANTS
      • 5.1.4 THREAT OF SUBSTITUTES
      • 5.1.5 INTENSITY OF RIVALRY
    • 5.2 VALUE CHAIN ANALYSIS
    • 5.3 INVESTMENT FEASIBILITY ANALYSIS
    • 5.4 PRICING ANALYSIS
  • 6 GLOBAL ROBOTICS PROSTHETICS MARKET, BY PRODUCTS

    • 6.1 INTRODUCTION
    • 6.2 PROSTHETIC ARMS
      • 6.2.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 6.3 PROSTHETIC FEET/ANKLES
      • 6.3.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 6.4 PROSTHETIC LEGS/KNEES
      • 6.4.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 6.5 PROSTHETIC HANDS
      • 6.5.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 6.6 OTHERS
      • 6.6.1 MARKET ESTIMATES & FORECAST, 2017-2027
  • 7 GLOBAL ROBOTICS PROSTHETICS MARKET, BY TECHNOLOGY

    • 7.1 INTRODUCTION
    • 7.2 PROSTHETIC FOOT MATERIALS
      • 7.2.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 7.3 BLUETOOTH
      • 7.3.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 7.4 MICROPROCESSOR KNEES
      • 7.4.1 MARKET ESTIMATES & FORECAST, 2017-2027
  • 8 GLOBAL ROBOTICS PROSTHETICS MARKET, BY APPLICATIONS

    • 8.1 INTRODUCTION
    • 8.2 LOWER BODY EXTREMITY
      • 8.2.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 8.3 UPPER BODY EXTREMITY
      • 8.3.1 MARKET ESTIMATES & FORECAST, 2017-2027
  • 9 GLOBAL ROBOTICS PROSTHETICS MARKET, BY END USER

    • 9.1 INTRODUCTION
    • 9.2 HOSPITALS
      • 9.2.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 9.3 CLINICS
      • 9.3.1 MARKET ESTIMATES & FORECAST, 2017-2027
    • 9.4 OTHERS
      • 9.4.1 MARKET ESTIMATES & FORECAST, 2017-2027
  • 10 GLOBAL ROBOTICS PROSTHETICS MARKET, BY REGION

    • 10.1 INTRODUCTION
    • 10.2 AMERICAS
      • 10.2.1 NORTH AMERICA
        • 10.2.1.1 U.S
        • 10.2.1.2 CANADA
      • 10.2.2 SOUTH AMERICA
    • 10.3 EUROPE
      • 10.3.1 WESTERN EUROPE
        • 10.3.1.1 GERMANY
        • 10.3.1.2 FRANCE
        • 10.3.1.3 U.K
        • 10.3.1.4 ITALY
        • 10.3.1.5 SPAIN
        • 10.3.1.6 REST OF WESTERN EUROPE
      • 10.3.2 EASTERN EUROPE
    • 10.4 ASIA PACIFIC
      • 10.4.1 JAPAN
      • 10.4.2 CHINA
      • 10.4.3 INDIA
      • 10.4.4 AUSTRALIA
      • 10.4.5 REPUBLIC OF KOREA
      • 10.4.6 REST OF ASIA PACIFIC
    • 10.5 THE MIDDLE EAST & AFRICA
      • 10.5.1 UNITED ARAB EMIRATES
      • 10.5.2 SAUDI ARABIA
      • 10.5.3 OMAN
      • 10.5.4 KUWAIT
      • 10.5.5 QATAR
      • 10.5.6 REST OF THE MIDDLE EAST & AFRICA
  • 11 COMPANY LANDSCAPE

    • 11.1 INTRODUCTION
    • 11.2 MARKET SHARE ANALYSIS
    • 11.3 KEY DEVELOPMENT & STRATEGIES
      • 11.3.1 KEY DEVELOPMENTS
  • 12 COMPANY PROFILES

    • 12.1 HDT GLOBAL, INC
      • 12.1.1 COMPANY OVERVIEW
      • 12.1.2 PRODUCT OVERVIEW
      • 12.1.3 FINANCIALS
      • 12.1.4 SWOT ANALYSIS
    • 12.2 TOUCH BIONICS INC
      • 12.2.1 COMPANY OVERVIEW
      • 12.2.2 PRODUCT OVERVIEW
      • 12.2.3 FINANCIAL OVERVIEW
      • 12.2.4 KEY DEVELOPMENTS
      • 12.2.5 SWOT ANALYSIS
    • 12.3 DR. FRESH LLC
      • 12.3.1 COMPANY OVERVIEW
      • 12.3.2 PRODUCT OVERVIEW
      • 12.3.3 FINANCIAL OVERVIEW
      • 12.3.4 KEY DEVELOPMENT
      • 12.3.5 SWOT ANALYSIS
    • 12.4 SYNTOUCH, LLC
      • 12.4.1 COMPANY OVERVIEW
      • 12.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
      • 12.4.3 FINANCIAL OVERVIEW
      • 12.4.4 KEY DEVELOPMENT
      • 12.4.5 SWOT ANALYSIS
    • 12.5 SHADOW ROBOT COMPANY
      • 12.5.1 COMPANY OVERVIEW
      • 12.5.2 PRODUCT OVERVIEW
      • 12.5.3 FINANCIAL OVERVIEW
      • 12.5.4 KEY DEVELOPMENTS
    • 12.6 STRYKER CORPORATION
      • 12.6.1 COMPANY OVERVIEW
      • 12.6.2 PRODUCT OVERVIEW
      • 12.6.3 FINANCIAL OVERVIEW
      • 12.6.4 KEY DEVELOPMENTS
    • 12.7 HANSEN MEDICAL, INC
      • 12.7.1 OVERVIEW
      • 12.7.2 PRODUCT OVERVIEW
      • 12.7.3 FINANCIALS
      • 12.7.4 KEY DEVELOPMENTS
      • 12.7.5 SWOT ANALYSIS
    • 12.8 ZOLL MEDICAL CORPORATION
      • 12.8.1 OVERVIEW
      • 12.8.2 PRODUCT OVERVIEW
      • 12.8.3 FINANCIALS
      • 12.8.4 KEY DEVELOPMENTS
      • 12.8.5 SWOT ANALYSIS
    • 12.9 MAZOR ROBOTICS LTD
      • 12.9.1 OVERVIEW
      • 12.9.2 PRODUCT OVERVIEW
      • 12.9.3 FINANCIALS
      • 12.9.4 KEY DEVELOPMENTS
      • 12.9.5 SWOT ANALYSIS
    • 12.10 OTHERS
  • 13 MRFR CONCLUSION

    • 13.1 KEY FINDINGS
      • 13.1.1 FROM CEO’S VIEW POINT
      • 13.1.2 UNMET NEEDS OF THE MARKET
    • 13.2 KEY COMPANIES TO WATCH
    • 13.3 PREDICTION OF PHARMACEUTICAL INDUSTRY
  • 14 APPENDIX

USD 4,950 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.